Is Bharat Parenterals a good quality company?

Past 10 year's financial track record analysis by Moneyworks4me indicates that Bharat Parenterals Ltd is a average quality company .

Is Bharat Parenterals undervalued or overvalued?

The key valuation ratios of Bharat Parenterals Ltd's currently when compared to its past seem to suggest it is in the Overvalued zone .

What is Bharat Parenterals share price return in the past 10 years?

Data is not available for this company

Is Bharat Parenterals a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Bharat Parenterals Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

Bharat Parenterals Ltd - Stock Valuation and Financial Performance

Name: Bharat Parenterals
Brand: Bharat Parenterals

BSE: 541096 | NSE: | Pharmaceuticals & Drugs | Small Cap

Place order

Bharat Parenterals Share Price

₹1,526.30 35.85 2.41%
as on 21-Nov'24 16:59

10 Year X-Ray of Bharat Parenterals:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Standalone Basis ^P Consolidated Basis ^P

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Value Creation ⓘ

Value Creation Index Colour Code Guide ⓘ

	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	TTM
ROCE % ⓘ	16.7%	15.2%	12.1%	19.2%	39.8%	31.7%	19.8%	17.6%	16.6%	13%	-
Value Creation Index ⓘ	0.2	0.1	-0.1	0.4	1.9	1.3	0.4	0.3	0.2	-0.1	-
Growth Parameters ⓘ Growth Parameters Colour Code Guide ⓘ
Sales ⓘ	119	124	111	136	220	226	204	212	218	254	281
Sales YoY Gr.	-	4.5%	-10.4%	22.6%	61.2%	3%	-10%	4.1%	2.8%	16.6%	-
Adj EPS ⓘ	12.8	11.5	11.4	14	36.3	42.4	34.3	36.1	29.2	35.3	37.5
YoY Gr.	-	-9.8%	-1.6%	23.6%	158.8%	16.6%	-19.1%	5.4%	-19.1%	20.7%	-
BVPS (₹) ⓘ	87.3	99	112	129.7	169	214.9	250.5	287.7	329.9	367.1	548.3
Adj Net Profit ⓘ	7.3	6.6	6.5	8	20.8	24.3	19.6	20.9	16.9	20.5	26
Cash Flow from Ops. ⓘ	9.4	0	-1.9	6.3	20.3	14.5	21.9	-22.1	-11.6	-22.9	-
Debt/CF from Ops. ⓘ	1.7	0	-3.4	1.4	0.2	0.1	0.6	-0.7	-4	-3.6	-

CAGR ⓘ

CAGR Colour Code Guide ⓘ

	9 Years	5 Years	3 Years	1 Years
Sales ⓘ	8.8%	3%	7.7%	16.6%
Adj EPS ⓘ	11.9%	-0.6%	1%	20.7%
BVPSⓘ	17.3%	16.8%	13.6%	11.3%
Share Price	-	53%	60.7%	172.6%

Key Financial Parameters ⓘ

Performance Ratio Colour Code Guide ⓘ

	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	TTM
Return on Equity % ⓘ	15.8	12.4	10.8	11.6	24.3	22.1	14.7	13.5	9.5	10.2	8.2
Op. Profit Mgn % ⓘ	9.2	8.3	6.3	9.7	13.8	13.4	12.3	13.8	10	11.5	11.1
Net Profit Mgn % ⓘ	6.2	5.3	5.9	5.9	9.5	10.7	9.6	9.8	7.7	8.1	9.2
Debt to Equity ⓘ	0.3	0.3	0.1	0.1	0.1	0	0.1	0.1	0.2	0.4	0
Working Cap Days ⓘ	215	220	229	223	169	200	189	199	276	337	152
Cash Conv. Cycle ⓘ	48	46	53	82	76	88	81	90	113	144	49

Recent Performance Summary

Sales growth is good in last 4 quarters at 16.96%

Return on Equity has declined versus last 3 years average to 8.20%

Sales growth has been subdued in last 3 years 7.66%

Latest Financials - Bharat Parenterals Ltd.

	Standalone	Consolidated
TTM EPS (₹)	37.5	-4
TTM Sales (₹ Cr.)	281	292
BVPS (₹.) ⓘ	548.3	489.9
Reserves (₹ Cr.) ⓘ	371	331
P/BV ⓘ	2.72	3.04
PE ⓘ	39.80	0.00

From the Market
52 Week Low / High (₹)	540.00 / 1854.00
All Time Low / High (₹)	116.25 / 1854.00
Market Cap (₹ Cr.)	1,027
Equity (₹ Cr.)	6.9
Face Value (₹)	10
Industry PE ⓘ	43

Management X-Ray of Bharat Parenterals:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged ^*

0.00

* Pledged shares as % of Promoter's holding (%)

Valuation of Bharat Parenterals

Price Calculator

Price Chart

Price to Earnings

Enterprise Value to EBIT

Price to Book-Value

Price to Sales

Dividend History

Analyst's Notes

This is a premium feature, Please click here to check our solutions.

Key Ratios of Bharat Parenterals

Standalone Basis Consolidated Basis

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24
Sales	119	124	111	136	220	226	204	212	218	254
Operating Expenses ⓘ	108	114	104	123	190	197	179	184	196	225
Manufacturing Costs	3	6	6	8	12	12	10	11	15	17
Material Costs	86	83	79	88	141	147	134	136	137	158
Employee Cost	7	9	11	12	14	14	14	15	17	20
Other Costs ⓘ	11	16	8	15	22	23	20	21	27	30
Operating Profit ⓘ	11	10	7	13	30	30	25	28	22	29
Operating Profit Margin (%)	9.2%	8.0%	6.3%	9.6%	13.7%	13.2%	12.3%	13.4%	9.9%	11.5%
Other Income ⓘ	4	5	8	7	13	12	9	8	19	12
Interest ⓘ	2	1	1	1	1	1	1	1	3	4
Depreciation ⓘ	4	4	6	6	6	6	6	7	6	6
Exceptional Items ⓘ	0	0	0	0	0	0	0	0	0	0
Profit Before Tax ⓘ	9	9	8	14	36	35	27	28	32	31
Tax ⓘ	1	3	1	4	13	9	7	7	8	8
Profit After Tax	7	6	7	10	23	26	20	21	24	23
PAT Margin (%)	6.3%	5.2%	6.6%	7.4%	10.3%	11.6%	9.9%	10.0%	11.2%	8.9%
Adjusted EPS (₹)	13.0	11.3	12.9	17.6	39.4	45.9	35.3	36.9	42.1	38.8
Dividend Payout Ratio (%)	0%	0%	0%	0%	0%	0%	0%	0%	2%	3%

Balance Sheet

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24
Equity and Liabilities
Shareholders Fund	50	57	64	74	97	123	144	166	191	214
Share Capital ⓘ	6	6	6	6	6	6	6	6	6	6
Reserves ⓘ	44	51	58	69	91	117	138	160	185	208
Minority Interest	0	0	0	0	0	0	0	0	0	0
Debt	16	19	4	7	3	1	10	13	43	80
Long Term Debt	12	7	4	2	1	1	9	10	7	4
Short Term Debt	5	13	0	5	2	0	1	3	36	76
Trade Payables	44	39	36	26	32	43	26	23	48	53
Others Liabilities ⓘ	6	5	6	23	30	26	17	17	27	41
Total Liabilities ⓘ	116	120	110	131	161	192	196	218	308	387
Fixed Assets
Gross Block	53	62	36	44	50	54	71	73	74	82
Accumulated Depreciation	24	28	5	10	16	22	28	33	39	43
Net Fixed Assetsⓘ	29	35	31	34	34	32	43	40	35	38
CWIP ⓘ	0	0	0	0	1	12	0	1	0	0
Investmentsⓘ	1	1	1	1	3	2	42	16	38	49
Inventories	13	14	15	14	21	28	22	21	38	54
Trade Receivables	58	44	44	59	66	82	68	73	112	140
Cash Equivalents	1	13	2	4	12	10	2	5	7	3
Others Assetsⓘ	14	14	18	19	24	27	19	63	77	103
Total Assets ⓘ	116	120	110	131	161	192	196	218	308	387

Cash Flow

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'15	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24
Cash Flow From Operating Activity ⓘ	9	-2	6	20	14	22	-22	-12	-23
PBT ⓘ	9	8	14	36	35	27	28	32	31
Adjustment ⓘ	6	6	6	7	6	6	5	1	5
Changes in Working Capital ⓘ	-4	-14	-11	-12	-17	-4	-49	-36	-49
Tax Paid ⓘ	-2	-2	-3	-10	-10	-7	-6	-9	-10
Cash Flow From Investing Activity ⓘ	-5	-2	-8	-9	-13	-41	22	-14	-16
Capex	-5	-2	-8	-9	-15	1	-5	5	-10
Net Investments	0	0	0	-1	1	-41	27	-22	-10
Others ⓘ	0	1	0	0	1	0	0	3	4
Cash Flow From Financing Activityⓘ	-7	-8	4	-4	-3	11	2	29	34
Net Proceeds from Shares ⓘ	0	0	0	0	0	0	0	0	0
Net Proceeds from Borrowing ⓘ	0	0	0	0	0	10	1	-3	-3
Interest Paid ⓘ	-2	-1	-1	-1	-1	0	-1	-2	-3
Dividend Paid ⓘ	0	0	0	0	0	0	0	0	0
Others ⓘ	-5	-7	5	-3	-2	1	2	33	41
Net Cash Flow ⓘ	-2	-11	2	7	-1	-8	2	3	-5

Finance Ratio

Standalone Basis Consolidated Basis

PARTICULARS	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24
Ratios
ROE (%)	16.04	12.1	12.21	14.59	26.38	23.92	15.16	13.76	13.65	11.18
ROCE (%)	16.65	15.21	12.09	19.15	39.83	31.68	19.8	17.59	16.62	13.02
Asset Turnover Ratio	1.2	1.11	1.03	1.15	1.5	1.28	1.22	1.16	0.96	0.82
PAT to CFO Conversion(x)	1.29	0	-0.29	0.6	0.87	0.54	1.1	-1.05	-0.5	-1
Working Capital Days
Receivable Days	137	142	136	136	103	119	115	107	134	162
Inventory Days	40	38	45	39	30	39	39	33	42	59
Payable Days	154	183	173	130	75	92	94	65	94	117

Bharat Parenterals Ltd Stock News

Bharat Parenterals Ltd FAQs

What is the share price of Bharat Parenterals?

Company share prices are keep on changing according to the market conditions. The closing price of Bharat Parenterals on 21-Nov-2024 16:59 is ₹1,526.3.

What is the market cap of Bharat Parenterals?

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 21-Nov-2024 16:59 the market cap of Bharat Parenterals stood at ₹1,027.2.